Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial

By sjmartinez • February 22, 2024

Lu MT, Ribaudo H, Foldyna B, Zanni MV, Mayrhofer T, Karady J, Taron J, Fitch KV, McCallum S, Burdo TH, Paradis K, Hedgire SS, Meyersohn NM, DeFilippi C, Malvestutto CD, Sturniolo A, Diggs M, Siminski S, Bloomfield GS, Alston-Smith B, Desvigne-Nickens P, Overton ET, Currier JS, Aberg JA, Fichtenbaum CJ, Hoffmann U, Douglas PS, Grinspoon SK; REPRIEVE Trial Writing Group. Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial. JAMA Cardiol. 2024 Feb 21. doi: 10.1001/jamacardio.2023.5661. Epub ahead of print. PMID: 38381407.

Tags: Infectious Diseases, Publications

Comparing generative artificial intelligence vs. experts for detection of catheter-associated urinary tract infection (CAUTI)

Alshanqeeti S, Coffey K, Mcdermott K, de Guzman A, Branch-Elliman W, Goodman KE, Harris AD, Baghdadi J, Morgan DJ. Comparing generative artificial intelligence vs. experts[...]

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept

Nadig N, Bhimraj A, Cawcutt K, Chiotos K, Dzierba AL, Kim AY, Martin GS, Pearson JC, Shumaker AH, Baden LR, Bedimo R, Cheng VC, Chew[...]

Prophage-encoded virulence factor, Gp05, contributes to endothelial cell dysfunction and immune evasion to promote persistent methicillin-resistant Staphylococcus aureus endovascular infections

Li Y, Manna AC, Ibrahim S, Proctor RA, Cheung AL, Xiong YQ. Prophage-encoded virulence factor, Gp05, contributes to endothelial cell dysfunction and immune evasion to[...]